The Hidden Architects of High Insulin Prices
How Corporate Middlemen Tripled Drug Prices and Blocked Cheaper Alternatives The Insulin Heist: How Corporate Middlemen Tripled Drug Prices and Blocked Cheaper Alternatives A cache of evidence reveals that pharmacy benefit managers systematically inflated list prices, excluded affordable generics, and…